BioXell
Latest round
- Series C
Last raised
- Mar 2006
Total raised
- $80M
Investors
- 10
About BioXell
BioXell is a clinical stage biopharmaceutical company, researches, discovers, and develops drug candidates for unmet medical needs in urology, inflammation, pain, and other related disorders.
Who invested in BioXell
10 investors across 4 rounds
See all investors in BioXell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BioXell
Who invested in BioXell?
BioXell has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioXell raised?
BioXell has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did BioXell last raise money?
BioXell's most recent round on record is a Series C, in Mar 2006.
What does BioXell do?
BioXell is a clinical stage biopharmaceutical company, researches, discovers, and develops drug candidates for unmet medical needs in urology, inflammation, pain, and other related disorders.
Where is BioXell headquartered?
BioXell is headquartered in Italy.
Which VCs invest in companies like BioXell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at BioXell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like BioXell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.